X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Elder Pharma with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ELDER PHARMA   MYLAN
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
MYLAN
Dec-14
ELDER PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs3804,285-   
Low Rs1883,019-   
Sales per share (Unadj.) Rs491.21,466.8-  
Earnings per share (Unadj.) Rs-3.2176.7-  
Cash flow per share (Unadj.) Rs14.4284.4-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs376.5729.1-  
Shares outstanding (eoy) m20.54378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x0.62.5 23.2%   
Avg P/E ratio x-89.320.7 -431.9%  
P/CF ratio (eoy) x19.712.8 153.5%  
Price / Book Value ratio x0.85.0 15.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m5,8331,381,812 0.4%   
No. of employees `000NA25.0 0.0%   
Total wages/salary Rs m2,1790-   
Avg. sales/employee Rs ThNM22,199.6-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM2,674.3-  
INCOME DATA
Net Sales Rs m10,089554,991 1.8%  
Other income Rs m257-3,235 -7.9%   
Total revenues Rs m10,346551,756 1.9%   
Gross profit Rs m-792138,029 -0.6%  
Depreciation Rs m36140,762 0.9%   
Interest Rs m2,75623,939 11.5%   
Profit before tax Rs m-3,65370,093 -5.2%   
Minority Interest Rs m0-288 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m1252,947 4.2%   
Profit after tax Rs m-6566,858 -0.1%  
Gross profit margin %-7.824.9 -31.6%  
Effective tax rate %-3.44.2 -81.5%   
Net profit margin %-0.612.0 -5.4%  
BALANCE SHEET DATA
Current assets Rs m9,240487,910 1.9%   
Current liabilities Rs m9,998381,448 2.6%   
Net working cap to sales %-7.519.2 -39.2%  
Current ratio x0.91.3 72.3%  
Inventory Days Days4678 59.3%  
Debtors Days Days60107 55.9%  
Net fixed assets Rs m10,124128,396 7.9%   
Share capital Rs m20619,626 1.0%   
"Free" reserves Rs m5,5820-   
Net worth Rs m7,734275,885 2.8%   
Long term debt Rs m4,889412,145 1.2%   
Total assets Rs m22,8821,111,240 2.1%  
Interest coverage x-0.33.9 -8.3%   
Debt to equity ratio x0.61.5 42.3%  
Sales to assets ratio x0.40.5 88.3%   
Return on assets %11.88.2 143.9%  
Return on equity %-0.824.2 -3.5%  
Return on capital %22.313.6 163.7%  
Exports to sales %3.00-   
Imports to sales %0.40-   
Net fx Rs m1810-   
CASH FLOW
From Operations Rs m11,75472,954 16.1%  
From Investments Rs m-561-57,534 1.0%  
From Financial Activity Rs m-6,762-19,223 35.2%  
Net Cashflow Rs m4,432-3,803 -116.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 71.89 Rs / USD

Compare ELDER PHARMA With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ELDER PHARMA With: AUROBINDO PHARMA  VENUS REMEDIES  DR. REDDYS LAB  DR. DATSONS LABS  DISHMAN PHARMA  



Today's Market

Indian Indices End Week Strong, Pharma Stocks Show Uptick(Pre-Open)

On Friday, share markets in India opened on a positive note and ended the day in green after a volatile day of trading.

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

Eris Lifesciences Limited (IPO)

Jun 15, 2017

Exposure to high margin specialty products offers promising growth prospects.

Laurus Labs Ltd (IPO)

Dec 6, 2016

Equitymaster analyses Initial Public Offering (IPO) of Laurus Labs, one of the leading supplier of APIs for ARVs and Hepatitis C.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

Does it Make Sense to Invest in Offshore Funds?(Outside View)

Nov 6, 2018

Many investors prefer to invest in offshore funds because of the rupee depreciation and on-going downtrend in the markets, but it is to be invested only when there is no option available to invest in India.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA 8-QTR ANALYSIS

COMPARE ELDER PHARMA WITH

MARKET STATS